The publication of University of Health Sciences Istanbul Sisli Hamidiye Etfal Application and Research Center.


Online article submission system has been turned over to eJManager. We kindly request you to submit your current article or new articles via eJManager system

          VOLUME 51 / ISSUE 2


The Journal is Indexed in


12 - Intraperitoneal catumaxomab for the treatment of malignant ascites: 4 cases

Esat Namal, Özgül Pamukçu Cerciz, Emel Gökmen, Burcu Kurt, Yağız Meriç Altun

Objective: To evaluate the efficacy of catumaxomab treatment for malignant ascites.

Cases: Four patients with malignant ascites who required paracentesis once or more a week and were considered for catumaxomab treatment, received catumaxomab following the therapeutical paracentesis, via intraperitoneal port catheter on the day 0., 3., 7. and 10. The frequency of paracentesis need and before and after the treatment wee compared and it was found that this frequency was decreased in each of the patients.

Conclusion: Catumaxomab therapy can be a good choice of treatment for the patients who suffer from malignant ascites and must be considered to improve particularly these patients’ quality of lives.

Keywords: Catumaxomab, malignant ascites, palliative care

To read full article click


Home Page       Editorial       Editorial Board       Advisory Board       Information for Authors       Contact       Archive

Copyright ® 2011 Sisli Etfal Hastanesi Tıp Bülteni